From Nobel to next-gen: Sweden’s quiet life sciences ascent
Sweden’s place on the frontier of science has a long history, with the capital Stockholm coming to a standstill every…
13 Oct 2025
New US biotech hubs showing potential amid onshoring request
Ever since its early roots, the US has been a key player in the pharmaceutical industry, with prominent names like Pfizer, Eli Lilly and Bristol Myers Squibb (BMS) all becoming…
10 Oct 2025
Pharma R&D set to endure despite rising MFN costs
Pharmaceutical research and development (R&D) is unlikely to be significantly impacted by most favored nation (MFN) pricing, according to industry experts. The US bears the highest drug costs globally, a…
30 Sep 2025
NewCo licensing models are tipping deals in favour of China’s biotechs
As pharma companies continue to license candidates developed in China, experts say a particular licensing model is allowing the country's burgeoning biotechs to leverage vast global capital and R&D while…
26 Sep 2025
The Baltics: a region punching above its weight on the global life sciences stage
Once best-known on the world stage as a country with a rich basketball history, a sport so deeply ingrained in Lithuanian national identity and culture it is considered by many…
23 Sep 2025
Magazine: China’s CGT edge
The cell and gene therapy (CGT) space continues to generate a lot of buzz. Amid ongoing funding challenges and getting clinical trials off the ground for Western biotechs, China is emerging…
19 Sep 2025
What does the EU Data Act mean for businesses?
On 12 September, the European Commission’s EU Data Act became applicable forcing many businesses operating within the continent to reconsider their approach to data management. The legislation, which took effect…